adenovirus type 4 vaccine live 32000 UNT Delayed Release Oral Tablet
- RxCUI
- 1099936
- RxNorm name
- adenovirus type 4 vaccine live 32000 UNT Delayed Release Oral Tablet
- Display name
- adenovirus type 4 vaccine live 32000 UNT Delayed Release Oral Tablet
- Full name
- adenovirus type 4 vaccine live 32000 UNT Delayed Release Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125296 | Adenovirus Type 4 and Type 7 Vaccine, Live, Oral | 351(a) | Rx | 2026-08-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c7d0b43c-7250-4809-8a05-fcde5862f076 | adenovirus type 4 vaccine, live 32,000 TCID50 Delayed Release Oral Tablet [PSN] · adenovirus type 4 vaccine live 32000 UNT Delayed Release Oral Tablet [SCD] | 2 | 14 | These highlights do not include all the information needed to use Adenovirus Type 4 and Type 7 Vaccine, Live, Oral safely and effectively. See full prescribing information for Adenovirus Type 4 and Type 7 Vaccine, Live, Oral. Adenovirus Type 4 and Type 7 Vaccine, Live, Oral Enteric Coated Tablets for Oral Administration Initial U.S. Approval: 2011 | 20220726 |